Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

Recognizing diverse presentations of folliculotropic mycosis fungoides is crucial to avoid diagnostic errors.

More research is needed to better understand and treat Fibrosing Frontal Alopecia.

Macrophages are more involved in Lichen planopilaris than in Frontal fibrosing alopecia.

Early biopsy and targeting inflammation can improve treatment for hair loss in androgenetic alopecia.

Foreign-body granuloma may be a marker for late-stage Lichen Planopilaris and should be considered in diagnosis.

Tofacitinib may help hair regrowth in familial alopecia areata with immune issues, but more research is needed.

Excessive sun protection might contribute to frontal fibrosing alopecia.

A 66-year-old woman experienced hair loss due to Frontal Fibrosing Alopecia, a condition with no consistently effective treatment, but it usually stabilizes over time. More research is needed for better understanding and treatment options.

Tildrakizumab significantly improved recalcitrant lichen planopilaris and frontal fibrosing alopecia.

A new genetic disorder caused by an ODC1 mutation can be treated with DFMO.

Frontal fibrosing alopecia often occurs after menopause, with delayed diagnosis and possible links to certain medications and conditions.

Dermoscopy helps diagnose frontal fibrosing alopecia by distinguishing it from other hair loss conditions.

Best treatment for Frontal Fibrosing Alopecia is 5-alpha-reductase inhibitors and intralesional corticosteroids.

Cosmetic products or emotional factors might contribute to Frontal Fibrosing Alopecia, and trichoscopy is useful for diagnosis.

Platelet-rich plasma (PRP) may help treat hair loss in patients with frontal fibrosing alopecia who don't respond to other treatments.

Postmenopausal frontal fibrosing alopecia is a type of hair loss in postmenopausal women that may stop on its own but has no effective treatment.

The pseudo 'fringe sign' can also appear in frontal fibrosing alopecia, not just in traction alopecia, showing that this condition may be more common than thought.

The document concludes that various childhood hair and nail disorders exist, some may improve on their own, and advances in genetics and immunology could enhance treatment and counseling.

Targeting EMT and fibrotic remodeling may help treat androgenetic alopecia.

Postmenopausal frontal fibrosing alopecia may be a unique condition linked to postmenopausal changes.

Tufted folliculitis is common in patients with folliculitis decalvans.

The patient's symptoms improved with treatment but recurred when the steroid dose was reduced, requiring ongoing therapy.

Frontal fibrosing alopecia can be diagnosed by examining facial areas and treated with specific medications to stop its progression.

Increased blood vessel growth in lichen planopilaris may signal active disease needing aggressive treatment.

Early diagnosis and a multidisciplinary approach are crucial for managing Frontal Fibrosing Alopecia.

The conclusion is that FFA and LPP have similar scalp biopsy features, making them hard to distinguish histologically, and FFA may be a specific kind of scarring hair loss.

The study found that treatment improved hair condition in patients with Fibrosing Alopecia in a Pattern Distribution in Chile.

Treatment with dapsone, topical corticosteroids, and antibiotics improved the man's skin conditions.

Children with darker skin can have various hair and nail issues.